Literature DB >> 19463933

Foreign protein production using plant cell and organ cultures: Advantages and limitations.

Sharon M-H Shih1, Pauline M Doran2.   

Abstract

Plants and plant tissue cultures are used as host systems for expression of foreign proteins including antibodies, vaccines and other therapeutic agents. Recombinant or stably transformed plants and plant cell cultures have been applied for foreign protein production for about 20 years. Because the product concentration achieved exerts a major influence on process economics, considerable efforts have been made by commercial and academic research groups to improve foreign protein expression levels. However, post-synthesis product losses due to protease activity within plant tissues and/or extracellular protein adsorption in plant cell cultures can negate the benefits of molecular or genetic enhancement of protein expression. Transient expression of foreign proteins using plant viral vectors is also a practical approach for producing foreign proteins in plants. Adaptation of this technology is required to allow infection and propagation of engineered viruses in plant tissue cultures for transient protein expression in vitro.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19463933     DOI: 10.1016/j.biotechadv.2009.05.009

Source DB:  PubMed          Journal:  Biotechnol Adv        ISSN: 0734-9750            Impact factor:   14.227


  11 in total

1.  On the way to commercializing plant cell culture platform for biopharmaceuticals: present status and prospect.

Authors:  Jianfeng Xu; Ningning Zhang
Journal:  Pharm Bioprocess       Date:  2014-12-01

Review 2.  Recent advances towards development and commercialization of plant cell culture processes for the synthesis of biomolecules.

Authors:  Sarah A Wilson; Susan C Roberts
Journal:  Plant Biotechnol J       Date:  2011-11-08       Impact factor: 9.803

3.  Passive immunoprotection targeting a secreted CAMP factor of Propionibacterium acnes as a novel immunotherapeutic for acne vulgaris.

Authors:  Pei-Feng Liu; Teruaki Nakatsuji; Wenhong Zhu; Richard L Gallo; Chun-Ming Huang
Journal:  Vaccine       Date:  2011-02-26       Impact factor: 3.641

4.  Human growth hormone expressed in tobacco cells as an arabinogalactan-protein fusion glycoprotein has a prolonged serum life.

Authors:  Jianfeng Xu; Shigeru Okada; Li Tan; Kenneth J Goodrum; John J Kopchick; Marcia J Kieliszewski
Journal:  Transgenic Res       Date:  2010-01-30       Impact factor: 2.788

5.  Production of pharmaceutical proteins in solanaceae food crops.

Authors:  Maria Manuela Rigano; Giorgio De Guzman; Amanda M Walmsley; Luigi Frusciante; Amalia Barone
Journal:  Int J Mol Sci       Date:  2013-01-29       Impact factor: 5.923

6.  Efficient Production of a Bioactive Bevacizumab Monoclonal Antibody Using the 2A Self-cleavage Peptide in Transgenic Rice Callus.

Authors:  Lei Chen; Xiaoyu Yang; Da Luo; Weichang Yu
Journal:  Front Plant Sci       Date:  2016-08-09       Impact factor: 5.753

7.  Pneumatic hydrodynamics influence transplastomic protein yields and biological responses during in vitro shoot regeneration of Nicotiana tabacum callus: Implications for bioprocess routes to plant-made biopharmaceuticals.

Authors:  Sherwin S Barretto; Franck Michoux; Klaus Hellgardt; Peter J Nixon
Journal:  Biochem Eng J       Date:  2017-01-15       Impact factor: 3.978

Review 8.  Improving pharmaceutical protein production in Oryza sativa.

Authors:  Yu-Chieh Kuo; Chia-Chun Tan; Jung-Ting Ku; Wei-Cho Hsu; Sung-Chieh Su; Chung-An Lu; Li-Fen Huang
Journal:  Int J Mol Sci       Date:  2013-04-24       Impact factor: 5.923

9.  Production of Bioactive Recombinant Bovine Chymosin in Tobacco Plants.

Authors:  Zheng-Yi Wei; Yu-Ying Zhang; Yun-Peng Wang; Ming-Xia Fan; Xiao-Fang Zhong; Nuo Xu; Feng Lin; Shao-Chen Xing
Journal:  Int J Mol Sci       Date:  2016-04-28       Impact factor: 5.923

Review 10.  Plants as bioreactors: Recent developments and emerging opportunities.

Authors:  Arun K Sharma; Manoj K Sharma
Journal:  Biotechnol Adv       Date:  2009-06-30       Impact factor: 14.227

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.